CIK 0001854270
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Senti Biosciences Holdings, Inc.
Sign in to watch- Ticker
- SNTI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 862437900
- Phone
- +1 650-239-2030
- Business address
- 2 CORPORATE DRIVE, FIRST FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Senti Biosciences, Inc., Senti Biosciences, Inc.\, Dynamics Special Purpose Corp.
- 4 Conversion Pres. & Chief Med. & Dev. Off. acquired 33,000 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Pres. & Chief Med. & Dev. Off. acquired 78,363 shares (grant or award)
- 4 Grant or award CEO and Interim PFO and PAO acquired 642,358 shares (grant or award)
- 4 Open-market sale CEO sold 4,467 shares at an average $4.11 ($18,339)
- 4 Open-market sale Pres. & Chief Med. & Dev. Off. sold 1,479 shares at an average $4.11 ($6,074)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 5 · 87 filings